The Regis Healthcare Ltd (ASX: REG) share price is in focus after the company announced FY26 underlying EBITDA is expected at about $135 million, hitting the top end of its guidance amid strong occupancy across mature homes.
What did Regis Healthcare report?
- FY26 underlying EBITDA expected to be approximately $135 million
- Average Q3 FY26 occupancy in mature homes reached 95.9%, up on the prior period
- Net refundable accommodation deposit (RAD) inflows of $223 million year to date (March FY26)
- Total paid-up RAD balance at $2.3 billion as at 31 March 2026
- One-off profit before tax of $25 million from divestment of two homes in Far North Queensland
What else do investors need to know?
Regis Healthcare’s ongoing momentum was supported by targeted sales initiatives and a tightening market for available beds. The company’s recent acquisitions, including Rockpool and OC Health, and room pricing adjustments also helped drive RAD inflows.
A structured cost-savings program is underway, focusing on streamlining management, improving operational efficiency, and adopting data analytics and AI tools to optimise workforce planning and automate processes. Regis is actively recycling capital, through both acquisitions and divestments, to strengthen its portfolio’s quality and earnings profile.
Regis is closely monitoring the Federal Government’s accommodation funding reforms and a new $3 billion package to support sector sustainability, with further details expected in the May 2026 Budget.
What did Regis Healthcare management say?
Managing Director and CEO Dr Linda Mellors said:
The release of the Accommodation Pricing Review and the Government’s initial funding response represent an important step toward improving the long-term sustainability of residential aged care. While further detail and consultation will be important, the direction of reform is positive and aligns with the sector’s need for a more sustainable funding and capital framework.
What’s next for Regis Healthcare?
Regis intends to keep investing in quality acquisitions and new developments in attractive locations, while continuing its efficiency and capital management push. Management will be watching the Federal Government Budget and aged care policy updates closely, considering their potential impact on funding and resident mix.
Over time, the progressive repricing of RADs is expected to deliver substantial operating cash inflows, supporting future growth and earnings.
Regis Healthcare share price snapshot
Over the past 12 months, Regis Healthcare shares have declined 5%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 6% over the same period.
The post Regis Healthcare expects FY26 EBITDA to hit top end of guidance appeared first on The Motley Fool Australia.
Should you invest $1,000 in Regis Healthcare right now?
Before you buy Regis Healthcare shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Regis Healthcare wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Mesoblast shares: Cash burn falls and Ryoncil® sales climb
- Liontown posts record net cash flow and hits underground mining targets
- Stockland reports higher 3Q26 sales and maintains FY26 guidance
- Woolworths Group Q3 sales grow as shoppers turn to value and convenience
- Mineral Resources upgrades FY26 volume guidance and posts robust lithium prices
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.